Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis
Brain Pathology · 2024
DOI: 10.1111/bpa.13237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, 2024. Verfasst von Gino Castillo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Laboratory Research-LID, Facultad de Ciencia e Ingeniería, Universidad Peruana Cayetano Heredia, Lima, Peru. Hauptthemen laut MEDLINE: Neurocysticercosis, Anthelmintics, Brain, Taenia solium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tropical Medicine Research Centers program-TMRC, Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica, NIAID NIH HHS.
Abstract (Originalsprache)
Despite being a leading cause of acquired seizures in endemic regions, the pathological mechanisms of neurocysticercosis are still poorly understood. This study aims to investigate the impact of anthelmintic treatment on neuropathological features in a rat model of neurocysticercosis. Rats were intracranially infected with Taenia solium oncospheres and treated with albendazole + praziquantel (ABZ), oxfendazole + praziquantel (OXF), or untreated placebo (UT) for 7 days. Following the last dose of treatment, brain tissues were evaluated at 24 h and 2 months. We performed neuropathological assessment for cyst damage, perilesional brain inflammation, presence of axonal spheroids, and spongy changes. Both treatments showed comparable efficacy in cyst damage and inflammation. The presence of spongy change correlated with spheroids counts and were not affected by anthelmintic treatment. Compared to white matter, gray matter showed greater spongy change (91.7% vs. 21.4%, p < 0.0001), higher spheroids count (45.2 vs. 0.2, p = 0.0001), and increased inflammation (72.0% vs. 21.4%, p = 0.003). In this rat model, anthelmintic treatment destroyed brain parasitic cysts at the cost of local inflammation similar to what is described in human neurocysticercosis. Axonal spheroids and spongy changes as markers of damage were topographically correlated, and not affected by anthelmintic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Laboratory Research-LID, Facultad de Ciencia e Ingeniería, Universidad Peruana Cayetano Heredia, Lima, Peru.
- Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, United States.
- The Department of International Health, Bloomberg School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Emergency Medicine, SUNY Downstate Medical Center, Kings County Hospital Medical Center, Brooklyn, New York, New York, United States.
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Facultad de Medicina Veterinaria y Salud animal, Universidad Peruana Cayetano Heredia, Lima, Peru.
ORCID-Profile: Gino Castillo, Robert H Gilman, Manuela Verastegui
Förderung
- Tropical Medicine Research Centers program-TMRC
- Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica
- NIAID NIH HHS
- NIH HHS
- FIC NIH HHS
- National Institutes of Health
Zitieren
APA
Castillo, G., Fustamante, L., Delgado-Kamiche, A. D., Camen-Orozco, R. P., Clark, T., Bernal, E., Morales-Alvarez, J., Ferrufino, M., Mamani-Palomino, J., Bustos, J. A., Garcia, H. H., Gavidia, C. M., Gilman, R. H., Verastegui, M., & Cysticercosis Working Group in Peru (2024). Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis. Brain Pathology. https://doi.org/10.1111/bpa.13237
Vancouver
Castillo G, Fustamante L, Delgado-Kamiche AD, Camen-Orozco RP, Clark T, Bernal E, et al. Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis. Brain Pathology. 2024. doi:10.1111/bpa.13237
BibTeX
@article{Castillo2024,
author = {Castillo, Gino and Fustamante, Lizbeth and Delgado-Kamiche, Ana D and Camen-Orozco, Rogger P and Clark, Taryn and Bernal, Edson and Morales-Alvarez, Jemima and Ferrufino, Maria and Mamani-Palomino, Javier and Bustos, Javier A and Garcia, Hector H and Gavidia, Cesar M and Gilman, Robert H and Verastegui, Manuela and Cysticercosis Working Group in Peru, Cysticercosis Working Group in Peru},
title = {Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis},
journal = {Brain Pathology},
year = {2024},
doi = {10.1111/bpa.13237}
}
EUVIMED